Home › NDC Lookup › RxCUI directory › RxCUI 996826

Methylergonovine maleate 0.2 MG Oral Tablet [Methergine] — RxCUI 996826

Name: Methylergonovine maleate 0.2 MG Oral Tablet [Methergine] (RxCUI 996826)
Creator: Brian Staiger, PharmD

RxNorm drug concept · Semantic branded drug

RxCUI 996826 Semantic branded drug · SBD ● Current RxNorm concept 1 FDA product 2 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by Dr. Brian Staiger, PharmD

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI996826

Official nameMethylergonovine maleate 0.2 MG Oral Tablet [Methergine]

Concept typeSemantic branded drug (SBD)

RxNorm statusCurrent RxNorm concept

Also known asMethergine 0.2 MG Oral Tablet

FDA products mapped1

Package NDCs mapped2

RxNorm release07/06/2026

Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Methylergonovine: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist

It's a medication given right after childbirth to help your uterus contract firmly and stop or prevent heavy bleeding. Sometimes the uterus doesn't tighten up on its own the way it...
What exactly is methylergonovine used for?
You'll typically take the tablet three or four times a day for up to one week after delivery, as your provider directs. One thing worth knowing: if you're taking it continuously in...
How should I take the tablet form, and is there anything I should know about timing?

📖 Read our full Methylergonovine guide →

🕸️ Concept Web — How Methylergonovine maleate 0.2 MG Oral Tablet [Met... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.

This page's concept Methylergonovine maleate 0.2 MG Oral Tablet [Methergine] RxCUI 996826 Semantic branded drug · SBD

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

Ingredients 2

The active substance itself — no strength, form, or brand attached yet.
- Methylergonovine 6883 IN
- Methylergonovine maleate 84158 PIN
Brand names 1

The same medicine's trade names. A brand name alone says nothing about strength or form.
- Methergine 227555 BN
Dose forms 13

The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
- Methylergonovine Oral Tablet 372859 SCDF
- Methylergonovine maleate Oral Tablet 2646335 SCDFP
- Methylergonovine Oral Product 1162887 SCDG
- Methylergonovine Pill 1162888 SCDG
- Methylergonovine maleate Oral Product 2663300 SCDGP
- Methylergonovine maleate Pill 2661754 SCDGP
- Methylergonovine Oral Tablet [Methergine] 368779 SBDF
- Methylergonovine maleate Oral Tablet [Methergine] 2656839 SBDFP
- +5 more in this family
Clinical & branded drugs 3

Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
- Methylergonovine maleate 0.2 MG Oral Tablet 996824 SCD
- Methylergonovine maleate 0.2 MG 996823 SCDC
- Methylergonovine maleate 0.2 MG [Methergine] 996825 SBDC

Showing up to 8 concepts per family — 14 of 19 stored related concepts drawn.

These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

Methylergonovine maleate 0.2 MG Oral Tablet SCD · 996824
Methylergonovine maleate 0.2 MG SCDC · 996823
Methylergonovine Oral Tablet SCDF · 372859
Methylergonovine maleate Oral Tablet SCDFP · 2646335
Methylergonovine Oral Product SCDG · 1162887
Methylergonovine Pill SCDG · 1162888
Methylergonovine maleate Oral Product SCDGP · 2663300
Methylergonovine maleate Pill SCDGP · 2661754

Brand-Name Concepts

Methylergonovine maleate 0.2 MG [Methergine] SBDC · 996825
Methylergonovine Oral Tablet [Methergine] SBDF · 368779
Methylergonovine maleate Oral Tablet [Methergine] SBDFP · 2656839
Methergine Oral Product SBDG · 1176928
Methergine Pill SBDG · 1176929
Methergine BN · 227555

📦 FDA Products & Package NDCs

1 product · 2 package NDCs

2 package NDCs map to RxCUI 996826 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.

Package NDC	Package	Brand / generic name	Labeler	Marketing start
27437-0050-56	28 TABLET in 1 BOTTLE (27437-050-56)	Methergine	Lupin Pharmaceuticals,Inc.	2016-04-04
27437-0050-57	12 TABLET in 1 BOTTLE (27437-050-57)	Methergine	Lupin Pharmaceuticals,Inc.	2016-04-04

Observed labelers: Lupin Pharmaceuticals,Inc. (2) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7

openFDA export observedJul 14, 2026

RxNorm release07/06/2026

Methodology2026-07-full-catalog-v1

A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.

This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.